Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Frequency Therapeutics, Inc. - Common Stock (NQ: FREQ )

N/A UNCHANGED
Last Price Updated: 4:00 PM EDT, Nov 3, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Frequency Therapeutics, Inc. - Common Stock

< Previous 1 2 3 4 5 6 Next >
INVESTOR ACTION REMINDER: The Schall Law Firm Reminds Investors of a Class Action Lawsuit Against Frequency Therapeutics, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Topics Lawsuit
Exposures Financial Legal
INVESTOR ALERT: Law Offices of Howard G. Smith Announces the Filing of a Securities Class Action on Behalf of Frequency Therapeutics, Inc. (FREQ) Investors
From Law Offices of Howard G. Smith
Via Business Wire
INVESTOR ALERT: Scott+Scott Attorneys at Law LLP Reminds Investors of a Securities Class Action Against Frequency, Inc. (NASDAQ: FREQ)
From Scott+Scott Attorneys at Law LLP
Via Business Wire
INVESTOR ACTION ALERT: The Schall Law Firm Reminds Investors of a Class Action Lawsuit Against Frequency Therapeutics, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Topics Lawsuit
Exposures Financial Legal
Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of Frequency Therapeutics, Inc. (FREQ) on Behalf of Investors
From Glancy Prongay & Murray LLP
Via Business Wire
The Law Offices of Frank R. Cruz Announces Investigation of Frequency Therapeutics, Inc. (FREQ) on Behalf of Investors
From The Law Offices of Frank R. Cruz
Via Business Wire
SHAREHOLDER ACTION NOTICE: The Schall Law Firm Reminds Investors of a Class Action Lawsuit Against Frequency Therapeutics, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Topics Lawsuit
Exposures Financial Legal
INVESTOR ALERT: Law Offices of Howard G. Smith Announces Investigation of Frequency Therapeutics, Inc. (FREQ) on Behalf of Investors
From Law Offices of Howard G. Smith
Via Business Wire
FREQUENCY THERAPEUTICS ALERT: Bragar Eagel & Squire, P.C. Announces That a Class Action Lawsuit Has Been Filed Against Frequency Therapeutics, Inc. and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire, P.C.
Via Business Wire
SHAREHOLDER ALERT: Robbins LLP Announces that Frequency Therapeutics, Inc. (FREQ) is Being Sued for Misleading Shareholders
From Robbins LLP
Via Business Wire
Notice of Lead Plaintiff Deadline for Shareholders in the Frequency Therapeutics, Inc. Class Action Lawsuit
From Robbins Geller Rudman & Dowd LLP
Via Business Wire
SHAREHOLDER ACTION ALERT: The Schall Law Firm Reminds Investors of a Class Action Lawsuit Against Frequency Therapeutics, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm
From The Schall Law Firm
Via Business Wire
FREQ BREAKING ALERT: Rosen Law Firm Encourages Frequency Therapeutics, Inc. Investors with Losses Exceeding $100K to Secure Counsel Before Important Deadline – FREQ
From Rosen Law Firm
Via Business Wire
INVESTOR ALERT: Scott+Scott Attorneys at Law LLP Files Securities Class Action Against Frequency, Inc. (NASDAQ: FREQ)
From Scott+Scott Attorneys at Law LLP
Via Business Wire
Frequency Therapeutics to Present at Upcoming Jefferies and Goldman Sachs Healthcare Investor Conferences
From Frequency Therapeutics, Inc.
Via Business Wire
Frequency Therapeutics, Inc. (NASDAQ:FREQ) Investor Notice: Investigation over Potential Wrongdoing
San Diego, CA -- (SBWIRE) -- 05/24/2021 -- Certain directors of Frequency Therapeutics, Inc are under investigation over potential breaches of fiduciary duties. 
Via SBWire
Frequency Therapeutics Provides Statement of Support for the Hearing Loss Association of America’s Externally-Led Patient-Focused Drug Development Meeting to Address Sensorineural Hearing Loss
From Frequency Therapeutics, Inc.
Via Business Wire
12 Health Care Stocks Moving In Wednesday's After-Market Session
Gainers VistaGen Therapeutics (NASDAQ:VTGN 
Via Benzinga
Scott+Scott Attorneys at Law LLP Announces Investigation into Frequency Therapeutics, Inc. (FREQ)
From Scott+Scott Attorneys at Law LLP
Via Business Wire
77 Biggest Movers From Yesterday
Gainers AMC Entertainment Holdings, Inc. (NYSE: AMC) shares surged 23.7% to close at $12.77. Moxian, Inc. (NASDAQ: MOXC) jumped 23.6% to close at $9.52. Repro Med Systems, Inc... 
Via Benzinga
Frequency Therapeutics Provides Business Updates and Reports First Quarter 2021 Financial Results
From Frequency Therapeutics, Inc.
Via Business Wire
3 Biotech Stocks That Could Be Millionaire-Makers
Their stocks have collapsed. But they could still be huge winners. 
Via The Motley Fool
Are Disappointing Results an Opportunity for Frequency Therapeutics Investors?
A risky path lies ahead for the clinical-stage biotech, which saw disappointing results for FX-322 in March 2021. Can management learn from its mistakes? 
Via The Motley Fool
Short Interest Through the End of March
ln aggregate for Russell 3,000 stocks, short interest as a percent of equity float is little changed versus where it stood in mid-March. But on an industry basis, there have been some large moves. 
Via Talk Markets
NASDAQ:FREQ Investor Notice: Investigation over Possible Securities Laws Violations by Frequency Therapeutics, Inc.
San Diego, CA -- (SBWIRE) -- 04/13/2021 -- An investigation was announced concerning potential securities laws violations by Frequency Therapeutics, Inc. in connection with certain financial... 
Via SBWire
Frequency Therapeutics Expands its Clinical Development Team, Adding Expertise in Inner Ear Physiology and Translational Science
From Frequency Therapeutics, Inc.
Via Business Wire
Frequency Therapeutics to Present at the 20th Annual Needham Virtual Healthcare Conference
From Frequency Therapeutics, Inc.
Via Business Wire
12 Health Care Stocks Moving In Wednesday's Intraday Session
Gainers Odonate Therapeutics (NASDAQ:ODT) stock moved upwards by 17.63% to $4.07 during Wednesday's regular session. Trading volume for this security as of 12:32 EST... 
Via Benzinga
< Previous 1 2 3 4 5 6 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.